The British Pharmacological Society welcomes the launch of a new review into opioid-containing medicines. An Expert Working Group of the UK’s Commission on Human Medicines will assess the available…
In December 2018, the House of Commons Health and Social Care Committee launched an inquiry on the usage of medicinal cannabis products as the first part of a wider inquiry into the…
A new British Journal of Clinical Pharmacology review examines the impact of cancer therapies on the skeleton and how to limit bone loss and fractures in cancer patients treated with these…
Approval has been granted for the development of a new national apprenticeship standard for the role of clinical pharmacology scientist, thanks to a cross-sector drive to address the skills…
On 30 January 2019, The Science and Technology Committee held an evidence session on Brexit, Science and Innovation: Preparations for ‘No-Deal’. The aim of the session was to explore…
The GMC is planning to introduce a process of credentialing in 2019 that will recognise expertise and provide training opportunities in areas of practice where there may be…
A new plan to tackle the threat of antimicrobial resistance (AMR) has been announced today by Secretary of State for Health and Social Care, Matt Hancock. Antibiotic resistance poses a…
In a Pharmacology Research & Perspectives study of individuals living in Olmsted County, Minnesota from 2005–12, potential overprescribing of antidepressant medications occurred in nearly…
A new British Journal of Clinical Pharmacology study illustrates the benefits of having clinical pharmacists follow up, by telephone, with patients at risk of having medication-related issues after…
In my first message to you as your President this time last year, I said that one of my priorities for 2018 was that our annual meeting would be our best yet. And based on what I saw at Pharmacology…
